Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
ZURICH Credit Suisse said on Friday it would fight on after a Texas appeals court upheld a $351 million award against the Swiss bank over its role in a Las Vegas resort project whose finances collapsed a decade ago.
MADRID/ZURICH Spain's Supreme Court ordered the arrest of former Catalan member of parliament Anna Gabriel after she failed to appear in court on Wednesday to answer charges related to the region's independence campaign.
MADRID/ZURICH Spain's Supreme Court ordered the arrest of former Catalan member of parliament Anna Gabriel after she failed to appear in court on Wednesday to answer charges related to the region's independence push.
ZURICH Swiss financial watchdog FINMA said on Wednesday it is investigating several Swiss banks over whether they followed anti-money laundering rules amid a widening $1 billion graft probe involving Venezuela's state oil company.
ZURICH Novartis's Sandoz division has won U.S. approval for a larger dosage of its Glatopa drug for multiple sclerosis (MS) patients, ending a costly delay that allowed rival generics makers to beat it to market.
ATHENS/ZURICH Greece's prime minister urged parliament on Monday to probe politicians in an alleged drug bribery case, while Swiss drugmaker Novartis promised to take action if an investigation found unethical conduct.
ZURICH Britain's healthcare watchdog (NICE) recommended Roche's medicine Gazyvaro for previously untreated advanced follicular lymphoma patients after initially rejecting the Swiss drugmaker's medicine last year as too expensive.
ZURICH A covert Swiss Cold War paramilitary group that operated largely outside civilian oversight until 1990 is back in the news after top-secret documents linked to the organisation vanished from official archives.
ZURICH Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker's immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals.
ZURICH Swiss drugmaker Roche expects erosion of Rituxan sales in Europe will intensify in 2018 as cheaper copies made by rivals gather momentum, its drug unit said on Thursday.